» Authors » Carol A Langford

Carol A Langford

Explore the profile of Carol A Langford including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 147
Citations 4181
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gul A, Langford C
Rheumatology (Oxford) . 2025 Mar; 64(Supplement_1):i120-i122. PMID: 40071406
Systemic vasculitis can present with different manifestations, some of which require unique approaches. This session at the 21st International Vasculitis Workshop, examined six studies focused on "Management of Special Situations"....
2.
Cronholm P, Applequist J, Krischer J, Fontenot E, Davis T, Burroughs C, et al.
BMC Med Res Methodol . 2024 Oct; 24(1):244. PMID: 39425055
Background: Traditional medical research infrastructures relying on the Centers of Excellence (CoE) model (an infrastructure or shared facility providing high standards of research excellence and resources to advance scientific knowledge)...
3.
Cunningham K, Hur B, Gupta V, Koster M, Weyand C, Cuthbertson D, et al.
Ann Rheum Dis . 2024 Aug; 83(12):1762-1772. PMID: 39153834
Objectives: This study aimed to identify plasma proteomic signatures that differentiate active and inactive giant cell arteritis (GCA) from non-disease controls. By comprehensively profiling the plasma proteome of both patients...
4.
Banerjee S, Rose E, Panicker S, Dugan J, Khalidi N, Koening C, et al.
ACR Open Rheumatol . 2024 Jul; 6(10):634-640. PMID: 39010674
Objective: Signal regulatory protein α (SIRPα) is found primarily on myeloid cells, including macrophages and neutrophils; binds to CD47; and regulates phagocytosis, antigen presentation, cellular fusion, cell proliferation, and migration....
5.
Kermani T, Sreih A, Cuthbertson D, Khalidi N, Koening C, Langford C, et al.
Rheumatology (Oxford) . 2024 Jun; 64(2):682-689. PMID: 38885370
Objectives: To evaluate damage and clinical characteristics associated with damage in Takayasu's arteritis (TAK). Methods: Patients with TAK enrolled in a multicentre, prospective, observational study underwent standardized damage assessment every...
6.
Borrego-Yaniz G, Ortiz-Fernandez L, Madrid-Paredes A, Kerick M, Hernandez-Rodriguez J, Mackie S, et al.
Lancet Rheumatol . 2024 May; 6(6):e374-e383. PMID: 38734017
Background: Giant cell arteritis is an age-related vasculitis that mainly affects the aorta and its branches in individuals aged 50 years and older. Current options for diagnosis and treatment are...
7.
Karadag O, Bolek E, Ayan G, Mohammad A, Grayson P, Pagnoux C, et al.
Arthritis Rheumatol . 2024 Feb; 76(7):1120-1129. PMID: 38343337
Objective: We describe the demographics, clinical features, disease course, and survival of polyarteritis nodosa (PAN) through an international collaboration (GLOBAL-PAN). Methods: Patients with PAN were recruited between 1990 and 2020...
8.
Almaani S, Song H, Suthanthira M, Toy C, Fussner L, Meara A, et al.
Kidney Int Rep . 2023 Nov; 8(11):2421-2427. PMID: 38025219
Introduction: Although the alternative complement pathway has been implicated in the pathogenesis of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV), the specific nature of its involvement is unclear. This study measured...
9.
Michailidou D, Grayson P, Hermanson P, Chapa J, Cuthbertson D, Khalidi N, et al.
Clin Immunol . 2023 Aug; 255:109746. PMID: 37625669
Markers of extracellular mitochondria are present in giant cell arteritis (GCA) patients. However, their role in promoting inflammation and platelet activation is no known. To investigate this, isolated mitochondria were...
10.
Bloom J, Pickett-Nairn K, Silveira L, Fuhlbrigge R, Cuthbertson D, Akuthota P, et al.
Arthritis Rheumatol . 2023 Jul; 75(12):2216-2227. PMID: 37433067
Objective: This study examined the relationship between age at diagnosis and disease characteristics and damage in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Methods: Analysis of a prospective longitudinal...